Recent news on Loprox

Local lawsuit to cost firm $9.8 million  -  May 9, 2007
Kansas City Star,Medicis Pharmaceutical Corp. of Scottsdale, Ariz., will pay the money to the government to settle allegations that it urged pediatricians to use Loprox as a

Medicis settles for $9.8 million  -  May 8, 2007
Arizona Republic,The issue centers on a former Medicis division that the government claims urged doctors to use Loprox as a treatment for diaper rash from November 2001

Medicis agrees to pay feds $9.8 mil  -  Mar 8, 2007
Arizona Republic,The Scottsdale company has agreed to pay federal investigators $9.8 million to settle claims that it improperly promoted its Loprox products, which include

Medicis Reports Fourth Quarter and Year End 2006 Financial Results  -  Feb 28, 2007
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox),

Medicis Announces 2006 Fourth Quarter and Year-End Conference Call ...  -  Feb 26, 2007
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis to Present At Roth Capital Partners 19th Annual OC Conference  -  Feb 15, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Perrigo's Ciclopirox Topical Suspension is the AB-rated equivalent to Medicis Pharma's Loprox Topical Suspension, 0.77%, indicated for the topical treatment

Medicis to Present At JPMorgan 25th Annual Healthcare Conference  -  Jan 4, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Wed: TASE regains record level  -  Dec 20, 2006
Globes,...announcement that it obtained US Food and Drug Administration (FDA) approval for its generic version of the antifungal topical treatment Loprox.

Perrigo Company Announces FDA Approval For Ciclopirox Topical ...  -  Dec 19, 2006
Drug Newswire (press release),The product is the AB-rated equivalent to Medicis Pharmaceutical's Loprox(R) Topical Suspension, 0.77%, an antifungal medication indicated for the topical

Perrigo OK'd on generic Loprox  -  Dec 19, 2006
United Press International19 (UPI) -- US firm Perrigo said Tuesday it has been approved for US sales of a generic version of Medicis' anti-fungal drug Loprox.

Perrigo Gets Approval for Generic Loprox  -  Dec 19, 2006
Forbes,...maker Perrigo Co. said Tuesday it received Food and Drug Administration approval for its generic version of the antifungal topical treatment Loprox.

Perrigo (PRGO) Receives FDA Approval for Ciclopirox Topical Suspension  -  Dec 19, 2006
StreetInsider.com (subscription),The product is the AB-rated equivalent to Medicis Pharmaceutical's Loprox Topical Suspension, 0.77%, an antifungal medication indicated for the topical

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,Perrigo's Ciclopirox Topical Suspension is the AB-rated equivalent to Medicis Pharma's Loprox Topical Suspension, 0.77%, indicated for the topical treatment

Wed: TASE regains record level  -  Dec 20, 2006
Globes,...announcement that it obtained US Food and Drug Administration (FDA) approval for its generic version of the antifungal topical treatment Loprox.

Medicis Declares Cash Dividend  -  Dec 14, 2006
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis Posts 3Q Loss on Writedowns  Nov 8, 2006
The bulk of that increase came from $52.6 million in charges related to writing down the value of the antifungal medication Loprox and the over-the-counter ... -Houston Chronicle, What is toenail fungus and what's the best way to get rid of it?  Nov 6, 2006
...shoes. Topical prescription solutions such as Loprox, Loceryl, Keralac, and Penlac may help, said Dr. Peter Paicos Jr. , immediate ... -Boston Globe, Medicis to Present at UBS Global Life Sciences Conference  Sep 22, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Medicis to Present at Credit Suisse Healthcare Conference  -  Nov 13, 2006
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis reports revenue down  Aug 3, 2006
...into the red because of a big payment for future product Reloxin, a tax bite on a fee paid by a former suitor and a slowdown in sales of key product Loprox. ... -East Valley Tribune

Medicis Announces Second Quarter 2006 Conference Call and Webcast  Jul 31, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Medicis Reports Second Quarter 2006 Financial Results  Aug 2, 2006
At the end of the June 2006 quarter, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R), PLEXION(R), RESTYLANE(R), SOLODYN(TM), TRIAZ(R) and ... -PrimeZone

Medicis Names Jason Hanson Executive Vice President and General ...  Jul 12, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Euronext Paris) - Ipsen : Medicis and Ipsen decide to focus ...  Jul 12, 2006
The Company's products include the prescription brands RESTYLANE®, DYNACIN® (minocycline HCl), LOPROX® (ciclopirox), OMNICEF® (cefdinir), PLEXION® (sodium ... -Euronext (persbericht)



Medicis Reports First Quarter 2006 Financial Results  May 9, 2006
2006 quarter primarily is attributable to a reduction in contract revenue of $15.3 million and continued generic erosion of the DYNACIN(R) and LOPROX(R) brands ... - PrimeZone

Medicis reports $88.5 million loss  May 10, 2006
Jonah Shacknai chalked that up to an expected reduction in contract revenue and the rise of generic alternatives for Medicis core products Dynacin and Loprox. ... - East Valley Tribune

Medicis Announces First Quarter 2006 Conference Call and Webcast  May 4, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - PrimeZone





(PZ) Medicis Reports December 2005 Financial Results  Mar 15, 2006
...revenue. The Company continues to experience erosion in our DYNACIN(R) and LOPROX(R) franchises due to generic competition. The ... - Houston Chronicle

(PZ) Medicis Declares Cash Dividend  Mar 15, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Houston Chronicle

Perrigo OK'd for generic Terazol  Mar 23, 2006
Earlier this month Perrigo got US approval for ciclopirox olamine cream, the generic version of Medicis Pharmaceutical's Loprox Cream, a topical cream used to ... - United Press International

Medicis 4Q Profit Jumps on Hefty Gain  Mar 15, 2006
The company said it continues to experience erosion in its Dynacin (oral antibiotic for acne) and Loprox (antifungal medication) franchises due to generic ... - Houston Chronicle

More Ways to Find Free Health Stuff for your Kids  Mar 31, 2006
...skin disorders, such as acne (Retin A Microgel, Tazorac, Benzaclin, Duac), eczema (Protopic, Elidel, Cutivate, Elocon) and ringworm (Loprox, Oxistat, Spectazole ... - About - News & Issues

UPDATE 2-Medicis operating profit, revenue fall  Mar 15, 2006
Revenue shrank on competition from cheaper generic versions of Medicis' Dynacin acne drug and Loprox medicated shampoo for scalp irritation. - Reuters

Medicis reports quarterly profit up but revenue down  Mar 16, 2006
...quarterly revenue was caused by new generic competition for two of the company’s top products — longtime industry leaders Dynacin and Loprox, Shacknai said ... - East Valley Tribune

Perrigo Company Announces Approval for Ciclopirox Olamine Cream  Mar 7, 2006
The product is the AB-rated equivalent to Medicis Pharmaceutical's Loprox(R) Cream, 0.77%, an anti-fungal medication indicated for the topical treatment of the ... - PR Newswire



THE MANY PROBLEMS OF OILY SKIN  Feb 6, 2006
...the skin yeast. Ketoconazole (Nizoral) and ciclopirox (Loprox) are available in foams, liquids, creams and ointments. The choice ... - Charlotte Sun-Herald,

THE MANY PROBLEMS OF OILY SKIN  Feb 6, 2006
...the skin yeast. Ketoconazole (Nizoral) and ciclopirox (Loprox) are available in foams, liquids, creams and ointments. The choice ... - Charlotte Sun-Herald

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional